There are 4 papers on paravalvular leak in aging research: 1 trial and 3 observational studies in people.
4 papers study it3 more mention it1 finding
1 new paper in 30 daysSee all 7 papers on paravalvular leak
- Human trial1
- Humans3
Interventions
1Tirzepatide
downin humans1
1 study
Tirzepatide
downin humans1
Tirzepatide decreases paravalvular leak in obese patients undergoing transfemoral TAVR (10.7% vs 25.3%; p = 0.006).
“and ≥ mild PVL (10.7% vs 25.3%, p = 0.006) at 6 months”
Human trialin obese patients undergoing transfemoral TAVR6 months
Cardiovascular revascularization medicine : including molecular interventions
Latest
3 papers in 12 monthsBMC Cardiovascular Disorders
Age matters? Investigating VARC-3 outcomes in surgical aortic valve reoperations: a multicenter study
Cohort study of 215 peoplePopulations
Cardiovascular Revascularization Medicine
Eyeballing versus comprehensive geriatric frailty assessment and outcomes after transcatheter aortic valve replacement: Insights from a large cohort
Cohort study of 6,343 peopleComprehensive geriatric assessment
Cardiovascular Revascularization Medicine
Tirzepatide therapy reduces subclinical leaflet thrombosis and paravalvular leak after transcatheter aortic valve replacement in obese patients: The TAVR-MET trial
Randomized trial in 260 peopleTirzepatide
Zhejiang Da Xue Xue Bao Yi Xue Ban
Impact of elevated arterial blood pressure on bioprosthetic valve calcification and failure after transcatheter aortic valve replacement
ReviewMechanisms
The Annals of Thoracic Surgery
Longitudinal Outcomes of Nonagenarians Undergoing Transcatheter Aortic Valve Replacement
Study in peopleInterventions